Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 8/2021

01-08-2021 | Care | Original Article

Attributable mortality of ICU acquired bloodstream infections: a propensity-score matched analysis

Authors: Nicolas Massart, Guilhem Wattecamps, Mikael Moriconi, Pierre Fillatre

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 8/2021

Login to get access

Abstract

The mortality attributable to ICU-acquired bloodstream infection (BSI) differs between studies due to statistical methods used for cohort matching. Propensity-score matching has never been used to avoid eventual bias when studying BSI attributable mortality in the ICU. We conducted an observational prospective study over a 4-year period, on patients admitted for at least 48 h in 2 intensive care units. Based on risk factors for death in the ICU and for BSI, each patient with BSI was matched with 3 patients without BSI using propensity-score matching. We performed a competitive risk analysis to study BSI mortality attributable fraction. Of 2464 included patients, 71 (2.9%) had a BSI. Propensity-score matching was highly effective and group characteristics were fully balanced. Crude mortality was 36.6% in patients with BSI and 21.6% in propensity-score matched patients (p=0.018). Attributable mortality of BSI was 2.3% [1.2–4.0] and number needed to harm was 6.7. With Fine and Gray model, a higher risk for death was observed in patients with BSI than in propensity-score matched patients (sub distribution Hazard Ratio (sdHR) = 2.11; 95% CI [1.32–3.37] p = 0.002). Patients with BSI had a higher risk for death and BSI attributable mortality fraction was 2.3%.
Appendix
Available only for authorised users
Literature
1.
go back to reference Vincent J, Rello J, Marshall J et al (2009) International Study of the Prevalence and Outcomes of Infection in Intensive Care Units. JAMA 302(21):2323–2329CrossRef Vincent J, Rello J, Marshall J et al (2009) International Study of the Prevalence and Outcomes of Infection in Intensive Care Units. JAMA 302(21):2323–2329CrossRef
2.
go back to reference Prowle JR, Echeverri JE, Ligabo EV, Sherry N, Taori GC, Crozier TM et al (2011) Acquired bloodstream infection in the intensive care unit: incidence and attributable mortality. Crit Care 15(2):R100CrossRef Prowle JR, Echeverri JE, Ligabo EV, Sherry N, Taori GC, Crozier TM et al (2011) Acquired bloodstream infection in the intensive care unit: incidence and attributable mortality. Crit Care 15(2):R100CrossRef
3.
go back to reference Adrie C, Garrouste-Orgeas M, Ibn Essaied W, Schwebel C, Darmon M, Mourvillier B et al (2017) Attributable mortality of ICU-acquired bloodstream infections: impact of the source, causative micro-organism, resistance profile and antimicrobial therapy. J Inf Secur 74:131–141 Adrie C, Garrouste-Orgeas M, Ibn Essaied W, Schwebel C, Darmon M, Mourvillier B et al (2017) Attributable mortality of ICU-acquired bloodstream infections: impact of the source, causative micro-organism, resistance profile and antimicrobial therapy. J Inf Secur 74:131–141
4.
go back to reference Garrouste-Orgeas M, Timsit JF, Tafflet M, Misset B, Zahar JR, Soufir L et al (2006) Excess risk of death from intensive care unit-acquired nosocomial bloodstream infections: a reappraisal. Clin Infect Dis 42:1118–1126CrossRef Garrouste-Orgeas M, Timsit JF, Tafflet M, Misset B, Zahar JR, Soufir L et al (2006) Excess risk of death from intensive care unit-acquired nosocomial bloodstream infections: a reappraisal. Clin Infect Dis 42:1118–1126CrossRef
5.
go back to reference Higuera F, Rangel-Frausto MS, Rosenthal VD, Soto JM, Castañon J, Franco G, Tabal-Galan N, Ruiz J, Duarte P, Graves N (2007) Attributable cost and length of stay for patients with central venous catheter-associated bloodstream infection in Mexico City intensive care units: a prospective, matched analysis. Infect Control Hosp Epidemiol 28:31–35CrossRef Higuera F, Rangel-Frausto MS, Rosenthal VD, Soto JM, Castañon J, Franco G, Tabal-Galan N, Ruiz J, Duarte P, Graves N (2007) Attributable cost and length of stay for patients with central venous catheter-associated bloodstream infection in Mexico City intensive care units: a prospective, matched analysis. Infect Control Hosp Epidemiol 28:31–35CrossRef
6.
go back to reference Thompson DS (2008) Estimates of the rate of acquisition of bacteraemia and associated excess mortality in a general intensive care unit: a 10 year study. J Hosp Infect 69:56–61CrossRef Thompson DS (2008) Estimates of the rate of acquisition of bacteraemia and associated excess mortality in a general intensive care unit: a 10 year study. J Hosp Infect 69:56–61CrossRef
7.
go back to reference Blot SI, Vandewoude KH, Colardyn FA (2003) Evaluation of outcome in critically ill patients with nosocomial enterobacter bacteremia: results of a matched cohort study. Chest. 123:1208–1213CrossRef Blot SI, Vandewoude KH, Colardyn FA (2003) Evaluation of outcome in critically ill patients with nosocomial enterobacter bacteremia: results of a matched cohort study. Chest. 123:1208–1213CrossRef
8.
go back to reference Rosenbaum PRRD (1983) The central role of the propensity score in observational studies for causal effects. Biometrika. 70:41–55CrossRef Rosenbaum PRRD (1983) The central role of the propensity score in observational studies for causal effects. Biometrika. 70:41–55CrossRef
9.
go back to reference Timsit JF, Zahar JR, Chevret S (2011) Attributable mortality of ventilator-associated pneumonia. Curr Opin Crit Care 17(5):464–471CrossRef Timsit JF, Zahar JR, Chevret S (2011) Attributable mortality of ventilator-associated pneumonia. Curr Opin Crit Care 17(5):464–471CrossRef
10.
go back to reference Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM (1988) CDC definitions for nosocomial infections, 1988. Am J Infect Control 16(3):128–140CrossRef Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM (1988) CDC definitions for nosocomial infections, 1988. Am J Infect Control 16(3):128–140CrossRef
11.
go back to reference Pneumonia (Ventilator-associated [VAP] and non-ventilator-associated Pneumonia [PNEU]) Event; Bloodstream Infection Event (Central Line-Associated Bloodstream Infection and Non-central Line Associated Bloodstream Infection); Urinary Tract Infection (Catheter-Associated Urinary Tract Infection [CAUTI] and Non-Catheter-Associated Urinary Tract Infection [UTI]) Events; Surgical Site Infection (SSI) Event available at https://www.cdc.gov/nhsn/PDFs/pscManual/6pscVAPcurrent.pdf and https://www.cdc.gov/nhsn/PDFs/pscManual/4PSC_CLABScurrent.pdf and https://www.cdc.gov/nhsn/PDFs/pscManual/7pscCAUTIcurrent.pdf and https://www.cdc.gov/nhsn/pdfs/pscmanual/9pscssicurrent.pdf. Accessed June 2020 Pneumonia (Ventilator-associated [VAP] and non-ventilator-associated Pneumonia [PNEU]) Event; Bloodstream Infection Event (Central Line-Associated Bloodstream Infection and Non-central Line Associated Bloodstream Infection); Urinary Tract Infection (Catheter-Associated Urinary Tract Infection [CAUTI] and Non-Catheter-Associated Urinary Tract Infection [UTI]) Events; Surgical Site Infection (SSI) Event available at https://​www.​cdc.​gov/​nhsn/​PDFs/​pscManual/​6pscVAPcurrent.​pdf and https://​www.​cdc.​gov/​nhsn/​PDFs/​pscManual/​4PSC_​CLABScurrent.​pdf and https://​www.​cdc.​gov/​nhsn/​PDFs/​pscManual/​7pscCAUTIcurrent​.​pdf and https://​www.​cdc.​gov/​nhsn/​pdfs/​pscmanual/​9pscssicurrent.​pdf. Accessed June 2020
14.
go back to reference Renaud B, Brun-Buisson C (2001) Outcomes of primary and catheter-related bacteremia. A cohort and case-control study in critically ill patients. Am J Respir Crit Care Med 163:1584–1590CrossRef Renaud B, Brun-Buisson C (2001) Outcomes of primary and catheter-related bacteremia. A cohort and case-control study in critically ill patients. Am J Respir Crit Care Med 163:1584–1590CrossRef
15.
go back to reference DiGiovine B, Chenoweth C, Watts C, Higgins M (2011) The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. J Antimicrob Chemother 66:1948–1953CrossRef DiGiovine B, Chenoweth C, Watts C, Higgins M (2011) The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. J Antimicrob Chemother 66:1948–1953CrossRef
16.
go back to reference Lepape A, Machut A, Savey A (2018) Réseau national Réa-Raisin de surveillance des infections acquises en réanimation adulte - Méthodes et principaux résultats. Méd Intensive Réanim 27(3):197–203CrossRef Lepape A, Machut A, Savey A (2018) Réseau national Réa-Raisin de surveillance des infections acquises en réanimation adulte - Méthodes et principaux résultats. Méd Intensive Réanim 27(3):197–203CrossRef
17.
go back to reference Tabah A, Koulenti D, Laupland K, Misset B, Valles J (2012) Bruzzi de Carvalho F, et al. Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study. Intensive Care Med 38(12):1930–1945CrossRef Tabah A, Koulenti D, Laupland K, Misset B, Valles J (2012) Bruzzi de Carvalho F, et al. Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study. Intensive Care Med 38(12):1930–1945CrossRef
18.
go back to reference de Santis V, Gresoiu M, Corona AM, Wilson APR, Singer M (2015) Bacteraemia incidence, causative organisms and resistance patterns, antibiotic strategies and outcomes in a single university hospital ICU: continuing improvement between 2000 and 2013. J Antimicrob Chemother 70(1):273–278CrossRef de Santis V, Gresoiu M, Corona AM, Wilson APR, Singer M (2015) Bacteraemia incidence, causative organisms and resistance patterns, antibiotic strategies and outcomes in a single university hospital ICU: continuing improvement between 2000 and 2013. J Antimicrob Chemother 70(1):273–278CrossRef
19.
go back to reference Sharek PJ, Benitz WE, Abel NJ, Freeburn MJ, Mayer ML, Bergman DA (2002) Effect of an Evidence-Based Hand Washing Policy on Hand Washing Rates and False-Positive Coagulase Negative Staphylococcus Blood and Cerebrospinal Fluid Culture Rates in a Level III NICU. J Perinatol 22(2):137–143CrossRef Sharek PJ, Benitz WE, Abel NJ, Freeburn MJ, Mayer ML, Bergman DA (2002) Effect of an Evidence-Based Hand Washing Policy on Hand Washing Rates and False-Positive Coagulase Negative Staphylococcus Blood and Cerebrospinal Fluid Culture Rates in a Level III NICU. J Perinatol 22(2):137–143CrossRef
21.
go back to reference European Centre for Disease Prevention and Control. Incidence and attributable mortality ofhealthcare-associated infections in intensive care units in Europe, 2008-2012. Stockholm: ECDC; 2018 European Centre for Disease Prevention and Control. Incidence and attributable mortality ofhealthcare-associated infections in intensive care units in Europe, 2008-2012. Stockholm: ECDC; 2018
22.
go back to reference Kang C-I, Kim S-H, Park WB, Lee K-D, Kim H-B, Kim E-C, Myoung-don O, Choe K-W (2005) Bloodstream Infections Caused by Antibiotic-Resistant Gram-Negative Bacilli: Risk Factors for Mortality and Impact of Inappropriate Initial Antimicrobial Therapy on Outcome. Antimicrob Agents Chemother 49(2):760–766CrossRef Kang C-I, Kim S-H, Park WB, Lee K-D, Kim H-B, Kim E-C, Myoung-don O, Choe K-W (2005) Bloodstream Infections Caused by Antibiotic-Resistant Gram-Negative Bacilli: Risk Factors for Mortality and Impact of Inappropriate Initial Antimicrobial Therapy on Outcome. Antimicrob Agents Chemother 49(2):760–766CrossRef
23.
go back to reference Girometti N, Lewis RE, Giannella M, Ambretti S, Bartoletti M, Tedeschi S et al (2014) Klebsiella pneumoniae Bloodstream Infection: Epidemiology and Impact of Inappropriate. Empirical Therapy. Medicine (Baltimore) 93(17):298–309CrossRef Girometti N, Lewis RE, Giannella M, Ambretti S, Bartoletti M, Tedeschi S et al (2014) Klebsiella pneumoniae Bloodstream Infection: Epidemiology and Impact of Inappropriate. Empirical Therapy. Medicine (Baltimore) 93(17):298–309CrossRef
Metadata
Title
Attributable mortality of ICU acquired bloodstream infections: a propensity-score matched analysis
Authors
Nicolas Massart
Guilhem Wattecamps
Mikael Moriconi
Pierre Fillatre
Publication date
01-08-2021
Publisher
Springer Berlin Heidelberg
Keyword
Care
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 8/2021
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-021-04215-4

Other articles of this Issue 8/2021

European Journal of Clinical Microbiology & Infectious Diseases 8/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine